Traumatic Brain Injuries Assessment And Management Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Devices (Imaging Devices (Magnetic Resonance Imaging (MRI) Devices, X-Ray, Computed Tomography, Others), Monitoring Devices), By Technique (Intracranial pressure monitoring, Partial pressure of oxygen in brain tissue (pBrO2)), By End-Use (Hospitals, Diagnostic centers, Others), By Region, and By Competition
Global Traumatic Brain Injuries Assessment And Management Devices Market was valued at USD 3.04 billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.31% through 2028. In the realm of business, the market is poised for growth due to several key factors. These include the increasing incidence of traumatic brain injuries (TBIs), a growing preference among patients for less invasive medical procedures, and a heightened awareness surrounding the treatment of brain injuries. Furthermore, the market is benefiting from the adoption of advanced technological solutions and favorable government policies. A notable example of this is the Australian government's commitment to the Traumatic Brain Injury mission, with an investment of USD 50 million in the 2019-2020 budget from the Medical Research Future Fund (MRFF), aimed at improving patient recovery from brain injuries.
Key Market Drivers
Increasing Prevalence of TBIs
Traumatic Brain Injuries (TBIs) have become a pressing global health issue, affecting millions of individuals each year. The increasing prevalence of TBIs is not only a concern for public health but is also driving the demand for advanced assessment and management devices.
A traumatic brain injury occurs when an external force, such as a blow to the head or a penetrating head injury, disrupts the normal functioning of the brain. TBIs can range from mild concussions to severe injuries with long-term consequences. The causes of TBIs are varied, encompassing accidents, sports-related injuries, falls, and even military combat situations. As these incidents become more prevalent, the demand for effective assessment and management devices is increasing, driven by several key factors.
The rise in TBI cases is fostering innovation in the field of assessment and management devices. Healthcare providers and medical researchers are continuously seeking more accurate, efficient, and less invasive tools to diagnose and treat TBIs. The urgent need to address this growing problem has given birth to a wave of cutting-edge technologies.
The increasing prevalence of TBIs is spurring the development of sophisticated diagnostic tools. These tools, such as advanced neuroimaging techniques and portable brain scanners, enable healthcare professionals to detect and assess brain injuries with higher precision. Early and accurate diagnosis is crucial for effective TBI management, and as a result, these devices are in high demand.
As the number of TBI cases surges, there is a heightened demand for devices that facilitate effective treatment. Management devices such as intracranial pressure monitors, ventilators, and rehabilitation tools are crucial for enhancing patient outcomes. They not only improve patient care but also provide a significant growth opportunity for the market.
The prevalence of TBIs is also pushing the boundaries of telemedicine and remote monitoring. With more individuals living in remote or underserved areas, the need for telehealth solutions has become increasingly evident. This is leading to the development of innovative remote assessment and management devices that can be used to provide real-time care to TBI patients, even in areas with limited access to specialized healthcare facilities.
Governments worldwide are recognizing the gravity of the TBI epidemic and are actively supporting research, development, and the deployment of assessment and management devices. For example, funding from government programs, like the Medical Research Future Fund (MRFF) in Australia, is driving advancements in the field. Government backing not only supports research but also ensures that innovative devices reach the market, promoting further growth.
Patient Preference for Minimally Invasive Procedures
In the ever-evolving landscape of healthcare, patient preferences play a pivotal role in shaping the direction of medical advancements. One notable trend in recent years is the increasing preference among patients for minimally invasive procedures. This shift in patient expectations is not only transforming the way healthcare is delivered but also driving innovation in medical technology. In the context of Traumatic Brain Injuries (TBIs), this preference is significantly boosting the growth of the Global Traumatic Brain Injuries Assessment and Management Devices Market.
Minimally invasive procedures have gained immense popularity in the medical field due to their potential benefits, including reduced pain, shorter hospital stays, quicker recovery times, and lower risk of complications. Patients are increasingly inclined towards these procedures, not only for the comfort and reduced recovery periods but also for the potential for better outcomes. This shift in patient expectations has significant implications for TBI assessment and management.
Traditionally, the assessment of TBIs often involved invasive procedures such as craniotomy, which could be both physically and emotionally distressing for patients. However, as patient preferences have leaned toward minimally invasive procedures, the demand for less intrusive assessment methods has grown. Advanced imaging technologies, including MRI and CT scans, now provide neurosurgeons and physicians with detailed insights into the extent and location of brain injuries, all without the need for invasive procedures. These non-invasive diagnostic methods align well with patient preferences and are in high demand. The Global TBI Assessment Devices Market has witnessed a surge in the development and adoption of such technologies.
Minimally invasive procedures also influence the management of TBIs. When surgical intervention is necessary, neurosurgeons are increasingly opting for techniques that minimize trauma to brain tissues. This includes the use of endoscopic procedures, neuronavigation systems, and robotic-assisted surgeries. The advent of innovative devices that aid in these minimally invasive management strategies has been met with enthusiasm by patients and healthcare providers alike. Patients are more willing to undergo procedures that involve smaller incisions, reduced pain, and shorter recovery periods, resulting in a higher demand for these advanced management devices.
The preference for minimally invasive procedures in TBI assessment and management is empowering patients. It allows them to actively participate in their healthcare decisions, reduces the physical and emotional burden of treatment, and enhances their overall experience. Additionally, the adoption of minimally invasive techniques often leads to better patient outcomes. Smaller incisions, reduced trauma, and faster recovery times translate into improved quality of life for TBI patients. This positive impact on patient outcomes further reinforces the demand for innovative assessment and management devices.
Increasing Awareness Regarding Brain Injury Treatment
Awareness of TBIs has been steadily rising, thanks to public health campaigns, media coverage, and education initiatives. Individuals, families, and healthcare professionals now have a better understanding of the severe consequences associated with brain injuries. This shift in awareness is driving several key factors that are positively impacting the assessment and management of TBIs.
As awareness increases, there is a growing emphasis on early detection and prompt treatment of TBIs. Individuals who may have previously dismissed head injuries as minor are now more likely to seek medical attention. This demand for timely diagnosis and intervention is fueling the development and adoption of assessment devices that can quickly and accurately detect brain injuries.
Preventing TBIs is a top priority, and awareness campaigns are crucial in educating people about injury prevention strategies. Helmets, seatbelts, safety regulations, and sports gear safety measures are becoming more widely adopted. Preventing TBIs from occurring in the first place is reducing the incidence of these injuries, yet at the same time, awareness continues to drive the demand for advanced assessment and management devices in cases where prevention is not possible.
Rising awareness translates to increased support for research and development in the field of TBI treatment. Government agencies, private organizations, and philanthropic entities are recognizing the importance of addressing TBIs and are actively investing in innovative solutions. This financial support is driving advancements in assessment and management devices, fostering market growth.
Awareness empowers patients to take an active role in their healthcare. Informed patients are more likely to advocate for the best available care, which includes the use of cutting-edge assessment and management devices. The partnership between patients and healthcare providers in the pursuit of superior TBI care is strengthening the market.
Increased awareness is fostering collaboration among healthcare institutions, research facilities, and medical device manufacturers. Researchers and engineers are coming together to develop innovative assessment and management devices that can address the pressing needs of TBI patients. These collaborative efforts are driving the market's growth and bringing groundbreaking solutions to the forefront.
Adoption of Technologically Advanced Products
Advancements in medical technology have ushered in a new era of TBI care, where precise diagnosis and effective management are increasingly achievable. The adoption of these innovative products is setting the stage for transformative improvements in the field of TBI assessment and management.
One of the key drivers behind the growth of the Global TBI Assessment Devices Market is the advent of advanced imaging technologies. High-resolution CT scans, MRI machines, and PET scans, enhanced with sophisticated software, provide healthcare professionals with the ability to detect even the most subtle brain injuries. This accuracy is paramount in guiding treatment decisions and improving patient outcomes.
The adoption of technologically advanced wearable and portable devices has become a game-changer in TBI assessment. Devices like smart helmets, head-worn sensors, and remote monitoring tools enable real-time tracking of brain activity and provide crucial data for diagnosing and managing TBIs. These portable solutions not only enhance patient comfort but also offer a continuous monitoring option, especially for patients at risk of further injury.
Robotic-assisted surgeries and neuro-navigation systems are revolutionizing TBI management. These technologies allow neurosurgeons to perform intricate procedures with greater precision and reduced invasiveness. The adoption of these advanced tools is raising the bar for TBI patient care, improving the chances of successful outcomes.
Telemedicine, powered by state-of-the-art communication and data transfer technologies, is bridging geographical gaps in TBI care. Patients in remote or underserved areas can access specialized expertise and assessment through telehealth solutions. The adoption of telemedicine is not only expanding access to care but also encouraging the development of innovative remote assessment and management devices.
Artificial intelligence (AI) and machine learning algorithms are increasingly integrated into TBI assessment and management devices. These technologies analyze complex data, aiding in the early detection of brain injuries and providing personalized treatment recommendations. The adoption of AI-powered devices is improving the speed and accuracy of diagnosis and treatment, which, in turn, is fueling market growth.
Key Market Challenges
Complex Nature of Brain Injuries
TBIs come in various forms, ranging from mild concussions to severe, life-altering injuries. The complexity of brain injuries presents a challenge in developing assessment and management devices that can cater to the diverse needs of TBI patients. One-size-fits-all solutions are often insufficient, requiring customization for individual cases.
Cost and Accessibility
Advanced TBI assessment and management devices can be costly. Accessibility to these technologies can be a significant challenge, especially for underserved populations or in regions with limited healthcare infrastructure. Ensuring that these innovations are available to all patients is a critical challenge.
Diagnostic Accuracy
While modern imaging technologies have greatly improved the accuracy of TBI diagnosis, challenges persist in identifying subtle brain injuries and differentiating them from other conditions. Developing assessment devices that can provide even more precise and timely diagnosis is a persistent challenge.
Key Market Trends
Personalized Treatment Plans
Personalized medicine is emerging as a prominent trend in TBI care. Rather than following a one-size-fits-all approach, healthcare providers are increasingly tailoring treatment plans to individual patients based on their unique needs and characteristics. This trend is expected to gain further traction, optimizing the effectiveness of treatment and enhancing patient satisfaction.
Interoperability and Standardization
Achieving interoperability and standardization among TBI assessment and management devices is a growing concern. Manufacturers and healthcare institutions are working to ensure that devices from different sources can seamlessly integrate and communicate. This trend will lead to a more connected and efficient healthcare ecosystem.
Ethical Considerations and Data Privacy
With the increasing use of technology, ethical considerations surrounding data privacy and patient consent are becoming more prominent. The market is likely to see greater emphasis on ethical guidelines and regulations to protect patient information and ensure that ethical standards are met.
Segmental Insights
Devices Insights
In 2022, the imaging devices segment secured the largest market share. This segment is further divided into Computed Tomography (CT) scans, Magnetic Resonance Imaging (MRI) devices, X-ray equipment, and others. Due to their heightened sensitivity, imaging devices are extensively utilized for evaluating patients with mild or severe Traumatic Brain Injuries (TBIs). Consequently, their usage in diagnosing and staging neurological diseases and disorders, particularly TBIs, is anticipated to boost this segment's growth. In March 2022, Swift Medical Inc. unveiled the Swift Ray 1, an innovative hardware device that can wirelessly connect to a smartphone camera. This device is a game-changer in wound care technology, as it captures comprehensive clinical data, significantly enhancing the assessment and monitoring of wound and skin conditions. The Swift Ray 1 is designed to be compact, fitting easily in a clinician's or patient's hand, enabling convenient and portable medical imaging. This groundbreaking technology empowers healthcare professionals to access powerful imaging capabilities, whether in a hospital or a patient's home. Over the 2023-2030 forecast period, the monitoring devices segment is projected to experience the most rapid CAGR. This can be attributed to the minimally invasive nature of these devices, increased awareness, and improvements in healthcare facilities. Moreover, factors like the enhanced accuracy of these devices, growing patient preference for non-invasive procedures, and strong physician preference for monitoring the progression of brain diseases are expected to drive growth in this segment during the forecast period.
Technique Insights
In 2022, the intracranial pressure monitoring segment took the lead in the market. This method is widely acknowledged as the benchmark for accurately measuring elevated intracranial pressure in patients with severe brain injuries. Numerous studies have emphasized that increased intracranial pressure is a primary cause of mortality in patients with Traumatic Brain Injuries (TBI). Consequently, ongoing intracranial pressure monitoring serves to maintain pressure levels within a healthy range and facilitates early and effective treatment. As a result, the advantages provided by intracranial pressure monitoring, coupled with the growing number of TBI patients, are anticipated to propel market growth.
On the other hand, the segment focused on monitoring the partial pressure of oxygen in brain tissue (pBrO2) is poised to exhibit the most rapid CAGR from 2023 to 2030. Continuous pBrO2 monitoring delivers timely insights into cerebral oxygen demand in individuals with TBI. These pBrO2 monitoring systems offer continuous tracking of the partial pressure of oxygen in brain tissue, thereby providing early indications of hypoxic events. These factors are expected to drive the growth of this segment during the forecast period.
Regional Insights
In 2022, North America asserted its dominance in the market. This can be attributed to the region's well-established healthcare infrastructure, the implementation of government initiatives, awareness campaigns about brain injuries, and a higher prevalence of Traumatic Brain Injuries (TBIs) in the continent. For instance, according to the Centers for Disease Control and Prevention (CDC), an estimated 2.87 million individuals in the United States experience brain injuries, and 1.5 million Americans sustain TBIs annually. Furthermore, in the U.S., in 2021, more than 5.3 million people lived with permanent TBI-related disabilities. These statistics involve approximately 2.5 million TBI-related emergency department visits, 288,000 hospitalizations, and 56,800 deaths, all contributing to the region's market growth.
Conversely, the Asia Pacific region is anticipated to exhibit the highest CAGR from 2023 to 2030. This projection is rooted in several factors, including the growing elderly population, an increase in TBI cases, a rise in the frequency of road accidents, and incidents of violence. For example, as reported by the Ministry of Road Transport and Highways, Government of India, there were a total of 4,12,432 road accidents in 2021, resulting in injuries to 3,84,448 individuals. Additionally, improved patient affordability has led to a significant upsurge in interventional procedures within the Asia Pacific region.
Key Market Players
Integra LifeSciences Corp
BioDirection Inc
Nihon Kohden Tokyo Corp
Compumedics Ltd
InfraScan Inc
Oculogica Inc
RAUMEDIC AG
Report Scope:
In this report, the Global Traumatic Brain Injuries Assessment And Management Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Traumatic Brain Injuries Assessment And Management Devices Market.
Available Customizations:
Global Traumatic Brain Injuries Assessment And Management Devices market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Key Market Drivers
Increasing Prevalence of TBIs
Traumatic Brain Injuries (TBIs) have become a pressing global health issue, affecting millions of individuals each year. The increasing prevalence of TBIs is not only a concern for public health but is also driving the demand for advanced assessment and management devices.
A traumatic brain injury occurs when an external force, such as a blow to the head or a penetrating head injury, disrupts the normal functioning of the brain. TBIs can range from mild concussions to severe injuries with long-term consequences. The causes of TBIs are varied, encompassing accidents, sports-related injuries, falls, and even military combat situations. As these incidents become more prevalent, the demand for effective assessment and management devices is increasing, driven by several key factors.
The rise in TBI cases is fostering innovation in the field of assessment and management devices. Healthcare providers and medical researchers are continuously seeking more accurate, efficient, and less invasive tools to diagnose and treat TBIs. The urgent need to address this growing problem has given birth to a wave of cutting-edge technologies.
The increasing prevalence of TBIs is spurring the development of sophisticated diagnostic tools. These tools, such as advanced neuroimaging techniques and portable brain scanners, enable healthcare professionals to detect and assess brain injuries with higher precision. Early and accurate diagnosis is crucial for effective TBI management, and as a result, these devices are in high demand.
As the number of TBI cases surges, there is a heightened demand for devices that facilitate effective treatment. Management devices such as intracranial pressure monitors, ventilators, and rehabilitation tools are crucial for enhancing patient outcomes. They not only improve patient care but also provide a significant growth opportunity for the market.
The prevalence of TBIs is also pushing the boundaries of telemedicine and remote monitoring. With more individuals living in remote or underserved areas, the need for telehealth solutions has become increasingly evident. This is leading to the development of innovative remote assessment and management devices that can be used to provide real-time care to TBI patients, even in areas with limited access to specialized healthcare facilities.
Governments worldwide are recognizing the gravity of the TBI epidemic and are actively supporting research, development, and the deployment of assessment and management devices. For example, funding from government programs, like the Medical Research Future Fund (MRFF) in Australia, is driving advancements in the field. Government backing not only supports research but also ensures that innovative devices reach the market, promoting further growth.
Patient Preference for Minimally Invasive Procedures
In the ever-evolving landscape of healthcare, patient preferences play a pivotal role in shaping the direction of medical advancements. One notable trend in recent years is the increasing preference among patients for minimally invasive procedures. This shift in patient expectations is not only transforming the way healthcare is delivered but also driving innovation in medical technology. In the context of Traumatic Brain Injuries (TBIs), this preference is significantly boosting the growth of the Global Traumatic Brain Injuries Assessment and Management Devices Market.
Minimally invasive procedures have gained immense popularity in the medical field due to their potential benefits, including reduced pain, shorter hospital stays, quicker recovery times, and lower risk of complications. Patients are increasingly inclined towards these procedures, not only for the comfort and reduced recovery periods but also for the potential for better outcomes. This shift in patient expectations has significant implications for TBI assessment and management.
Traditionally, the assessment of TBIs often involved invasive procedures such as craniotomy, which could be both physically and emotionally distressing for patients. However, as patient preferences have leaned toward minimally invasive procedures, the demand for less intrusive assessment methods has grown. Advanced imaging technologies, including MRI and CT scans, now provide neurosurgeons and physicians with detailed insights into the extent and location of brain injuries, all without the need for invasive procedures. These non-invasive diagnostic methods align well with patient preferences and are in high demand. The Global TBI Assessment Devices Market has witnessed a surge in the development and adoption of such technologies.
Minimally invasive procedures also influence the management of TBIs. When surgical intervention is necessary, neurosurgeons are increasingly opting for techniques that minimize trauma to brain tissues. This includes the use of endoscopic procedures, neuronavigation systems, and robotic-assisted surgeries. The advent of innovative devices that aid in these minimally invasive management strategies has been met with enthusiasm by patients and healthcare providers alike. Patients are more willing to undergo procedures that involve smaller incisions, reduced pain, and shorter recovery periods, resulting in a higher demand for these advanced management devices.
The preference for minimally invasive procedures in TBI assessment and management is empowering patients. It allows them to actively participate in their healthcare decisions, reduces the physical and emotional burden of treatment, and enhances their overall experience. Additionally, the adoption of minimally invasive techniques often leads to better patient outcomes. Smaller incisions, reduced trauma, and faster recovery times translate into improved quality of life for TBI patients. This positive impact on patient outcomes further reinforces the demand for innovative assessment and management devices.
Increasing Awareness Regarding Brain Injury Treatment
Awareness of TBIs has been steadily rising, thanks to public health campaigns, media coverage, and education initiatives. Individuals, families, and healthcare professionals now have a better understanding of the severe consequences associated with brain injuries. This shift in awareness is driving several key factors that are positively impacting the assessment and management of TBIs.
As awareness increases, there is a growing emphasis on early detection and prompt treatment of TBIs. Individuals who may have previously dismissed head injuries as minor are now more likely to seek medical attention. This demand for timely diagnosis and intervention is fueling the development and adoption of assessment devices that can quickly and accurately detect brain injuries.
Preventing TBIs is a top priority, and awareness campaigns are crucial in educating people about injury prevention strategies. Helmets, seatbelts, safety regulations, and sports gear safety measures are becoming more widely adopted. Preventing TBIs from occurring in the first place is reducing the incidence of these injuries, yet at the same time, awareness continues to drive the demand for advanced assessment and management devices in cases where prevention is not possible.
Rising awareness translates to increased support for research and development in the field of TBI treatment. Government agencies, private organizations, and philanthropic entities are recognizing the importance of addressing TBIs and are actively investing in innovative solutions. This financial support is driving advancements in assessment and management devices, fostering market growth.
Awareness empowers patients to take an active role in their healthcare. Informed patients are more likely to advocate for the best available care, which includes the use of cutting-edge assessment and management devices. The partnership between patients and healthcare providers in the pursuit of superior TBI care is strengthening the market.
Increased awareness is fostering collaboration among healthcare institutions, research facilities, and medical device manufacturers. Researchers and engineers are coming together to develop innovative assessment and management devices that can address the pressing needs of TBI patients. These collaborative efforts are driving the market's growth and bringing groundbreaking solutions to the forefront.
Adoption of Technologically Advanced Products
Advancements in medical technology have ushered in a new era of TBI care, where precise diagnosis and effective management are increasingly achievable. The adoption of these innovative products is setting the stage for transformative improvements in the field of TBI assessment and management.
One of the key drivers behind the growth of the Global TBI Assessment Devices Market is the advent of advanced imaging technologies. High-resolution CT scans, MRI machines, and PET scans, enhanced with sophisticated software, provide healthcare professionals with the ability to detect even the most subtle brain injuries. This accuracy is paramount in guiding treatment decisions and improving patient outcomes.
The adoption of technologically advanced wearable and portable devices has become a game-changer in TBI assessment. Devices like smart helmets, head-worn sensors, and remote monitoring tools enable real-time tracking of brain activity and provide crucial data for diagnosing and managing TBIs. These portable solutions not only enhance patient comfort but also offer a continuous monitoring option, especially for patients at risk of further injury.
Robotic-assisted surgeries and neuro-navigation systems are revolutionizing TBI management. These technologies allow neurosurgeons to perform intricate procedures with greater precision and reduced invasiveness. The adoption of these advanced tools is raising the bar for TBI patient care, improving the chances of successful outcomes.
Telemedicine, powered by state-of-the-art communication and data transfer technologies, is bridging geographical gaps in TBI care. Patients in remote or underserved areas can access specialized expertise and assessment through telehealth solutions. The adoption of telemedicine is not only expanding access to care but also encouraging the development of innovative remote assessment and management devices.
Artificial intelligence (AI) and machine learning algorithms are increasingly integrated into TBI assessment and management devices. These technologies analyze complex data, aiding in the early detection of brain injuries and providing personalized treatment recommendations. The adoption of AI-powered devices is improving the speed and accuracy of diagnosis and treatment, which, in turn, is fueling market growth.
Key Market Challenges
Complex Nature of Brain Injuries
TBIs come in various forms, ranging from mild concussions to severe, life-altering injuries. The complexity of brain injuries presents a challenge in developing assessment and management devices that can cater to the diverse needs of TBI patients. One-size-fits-all solutions are often insufficient, requiring customization for individual cases.
Cost and Accessibility
Advanced TBI assessment and management devices can be costly. Accessibility to these technologies can be a significant challenge, especially for underserved populations or in regions with limited healthcare infrastructure. Ensuring that these innovations are available to all patients is a critical challenge.
Diagnostic Accuracy
While modern imaging technologies have greatly improved the accuracy of TBI diagnosis, challenges persist in identifying subtle brain injuries and differentiating them from other conditions. Developing assessment devices that can provide even more precise and timely diagnosis is a persistent challenge.
Key Market Trends
Personalized Treatment Plans
Personalized medicine is emerging as a prominent trend in TBI care. Rather than following a one-size-fits-all approach, healthcare providers are increasingly tailoring treatment plans to individual patients based on their unique needs and characteristics. This trend is expected to gain further traction, optimizing the effectiveness of treatment and enhancing patient satisfaction.
Interoperability and Standardization
Achieving interoperability and standardization among TBI assessment and management devices is a growing concern. Manufacturers and healthcare institutions are working to ensure that devices from different sources can seamlessly integrate and communicate. This trend will lead to a more connected and efficient healthcare ecosystem.
Ethical Considerations and Data Privacy
With the increasing use of technology, ethical considerations surrounding data privacy and patient consent are becoming more prominent. The market is likely to see greater emphasis on ethical guidelines and regulations to protect patient information and ensure that ethical standards are met.
Segmental Insights
Devices Insights
In 2022, the imaging devices segment secured the largest market share. This segment is further divided into Computed Tomography (CT) scans, Magnetic Resonance Imaging (MRI) devices, X-ray equipment, and others. Due to their heightened sensitivity, imaging devices are extensively utilized for evaluating patients with mild or severe Traumatic Brain Injuries (TBIs). Consequently, their usage in diagnosing and staging neurological diseases and disorders, particularly TBIs, is anticipated to boost this segment's growth. In March 2022, Swift Medical Inc. unveiled the Swift Ray 1, an innovative hardware device that can wirelessly connect to a smartphone camera. This device is a game-changer in wound care technology, as it captures comprehensive clinical data, significantly enhancing the assessment and monitoring of wound and skin conditions. The Swift Ray 1 is designed to be compact, fitting easily in a clinician's or patient's hand, enabling convenient and portable medical imaging. This groundbreaking technology empowers healthcare professionals to access powerful imaging capabilities, whether in a hospital or a patient's home. Over the 2023-2030 forecast period, the monitoring devices segment is projected to experience the most rapid CAGR. This can be attributed to the minimally invasive nature of these devices, increased awareness, and improvements in healthcare facilities. Moreover, factors like the enhanced accuracy of these devices, growing patient preference for non-invasive procedures, and strong physician preference for monitoring the progression of brain diseases are expected to drive growth in this segment during the forecast period.
Technique Insights
In 2022, the intracranial pressure monitoring segment took the lead in the market. This method is widely acknowledged as the benchmark for accurately measuring elevated intracranial pressure in patients with severe brain injuries. Numerous studies have emphasized that increased intracranial pressure is a primary cause of mortality in patients with Traumatic Brain Injuries (TBI). Consequently, ongoing intracranial pressure monitoring serves to maintain pressure levels within a healthy range and facilitates early and effective treatment. As a result, the advantages provided by intracranial pressure monitoring, coupled with the growing number of TBI patients, are anticipated to propel market growth.
On the other hand, the segment focused on monitoring the partial pressure of oxygen in brain tissue (pBrO2) is poised to exhibit the most rapid CAGR from 2023 to 2030. Continuous pBrO2 monitoring delivers timely insights into cerebral oxygen demand in individuals with TBI. These pBrO2 monitoring systems offer continuous tracking of the partial pressure of oxygen in brain tissue, thereby providing early indications of hypoxic events. These factors are expected to drive the growth of this segment during the forecast period.
Regional Insights
In 2022, North America asserted its dominance in the market. This can be attributed to the region's well-established healthcare infrastructure, the implementation of government initiatives, awareness campaigns about brain injuries, and a higher prevalence of Traumatic Brain Injuries (TBIs) in the continent. For instance, according to the Centers for Disease Control and Prevention (CDC), an estimated 2.87 million individuals in the United States experience brain injuries, and 1.5 million Americans sustain TBIs annually. Furthermore, in the U.S., in 2021, more than 5.3 million people lived with permanent TBI-related disabilities. These statistics involve approximately 2.5 million TBI-related emergency department visits, 288,000 hospitalizations, and 56,800 deaths, all contributing to the region's market growth.
Conversely, the Asia Pacific region is anticipated to exhibit the highest CAGR from 2023 to 2030. This projection is rooted in several factors, including the growing elderly population, an increase in TBI cases, a rise in the frequency of road accidents, and incidents of violence. For example, as reported by the Ministry of Road Transport and Highways, Government of India, there were a total of 4,12,432 road accidents in 2021, resulting in injuries to 3,84,448 individuals. Additionally, improved patient affordability has led to a significant upsurge in interventional procedures within the Asia Pacific region.
Key Market Players
Integra LifeSciences Corp
BioDirection Inc
Nihon Kohden Tokyo Corp
Compumedics Ltd
InfraScan Inc
Oculogica Inc
RAUMEDIC AG
Report Scope:
In this report, the Global Traumatic Brain Injuries Assessment And Management Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Traumatic Brain Injuries Assessment And Management Devices Market, By Devices:
- Imaging Devices
- Magnetic Resonance Imaging (MRI) Devices
- X-Ray
- Computed Tomography
- Others
- Monitoring Devices
- Traumatic Brain Injuries Assessment And Management Devices Market, By Technique:
- Intracranial pressure monitoring
- Partial pressure of oxygen in brain tissue (pBrO2)
- Traumatic Brain Injuries Assessment And Management Devices Market, By End-Use:
- Hospitals
- Diagnostic centers
- Others
- Traumatic Brain Injuries Assessment And Management Devices Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Global Traumatic Brain Injuries Assessment And Management Devices Market.
Available Customizations:
Global Traumatic Brain Injuries Assessment And Management Devices market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL TRAUMATIC BRAIN INJURIES ASSESSMENT AND MANAGEMENT DEVICES MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Devices (Imaging Devices (Magnetic Resonance Imaging (MRI) Devices, X-Ray, Computed Tomography, Others), Monitoring Devices)
5.2.2. By Technique (Intracranial pressure monitoring, Partial pressure of oxygen in brain tissue (pBrO2))
5.2.3. By End-Use (Hospitals, Diagnostic centers, Others)
5.2.4. By Region
5.2.5. By Company (2022)
5.3. Product Market Map
5.3.1. By Devices
5.3.2. By Technique
5.3.3. By End-Use
5.3.4. By Region
6. NORTH AMERICA TRAUMATIC BRAIN INJURIES ASSESSMENT AND MANAGEMENT DEVICES MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Devices (Imaging Devices (Magnetic Resonance Imaging (MRI) Devices, X-Ray, Computed Tomography, Others), Monitoring Devices)
6.2.2. By Technique (Intracranial pressure monitoring, Partial pressure of oxygen in brain tissue (pBrO2))
6.2.3. By End-Use (Hospitals, Diagnostic centers, Others)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Traumatic Brain Injuries Assessment And Management Devices Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Devices
6.3.1.2.2. By Technique
6.3.1.2.3. By End-Use
6.3.2. Canada Traumatic Brain Injuries Assessment And Management Devices Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Devices
6.3.2.2.2. By Technique
6.3.2.2.3. By End-Use
6.3.3. Mexico Traumatic Brain Injuries Assessment And Management Devices Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Devices
6.3.3.2.2. By Technique
6.3.3.2.3. By End-Use
7. EUROPE TRAUMATIC BRAIN INJURIES ASSESSMENT AND MANAGEMENT DEVICES MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Devices (Imaging Devices (Magnetic Resonance Imaging (MRI) Devices, X-Ray, Computed Tomography, Others), Monitoring Devices)
7.2.2. By Technique (Intracranial pressure monitoring, Partial pressure of oxygen in brain tissue (pBrO2))
7.2.3. By End-Use (Hospitals, Diagnostic centers, Others)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Traumatic Brain Injuries Assessment And Management Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Devices
7.3.1.2.2. By Technique
7.3.1.2.3. By End-Use
7.3.2. United Kingdom Traumatic Brain Injuries Assessment And Management Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Devices
7.3.2.2.2. By Technique
7.3.2.2.3. By End-Use
7.3.3. France Traumatic Brain Injuries Assessment And Management Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Devices
7.3.3.2.2. By Technique
7.3.3.2.3. By End-Use
7.3.4. Italy Traumatic Brain Injuries Assessment And Management Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Devices
7.3.4.2.2. By Technique
7.3.4.2.3. By End-Use
7.3.5. Spain Traumatic Brain Injuries Assessment And Management Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Devices
7.3.5.2.2. By Technique
7.3.5.2.3. By End-Use
8. ASIA-PACIFIC TRAUMATIC BRAIN INJURIES ASSESSMENT AND MANAGEMENT DEVICES MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Devices (Imaging Devices (Magnetic Resonance Imaging (MRI) Devices, X-Ray, Computed Tomography, Others), Monitoring Devices)
8.2.2. By Technique (Intracranial pressure monitoring, Partial pressure of oxygen in brain tissue (pBrO2))
8.2.3. By End-Use (Hospitals, Diagnostic centers, Others)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Traumatic Brain Injuries Assessment And Management Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Devices
8.3.1.2.2. By Technique
8.3.1.2.3. By End-Use
8.3.2. Japan Traumatic Brain Injuries Assessment And Management Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Devices
8.3.2.2.2. By Technique
8.3.2.2.3. By End-Use
8.3.3. India Traumatic Brain Injuries Assessment And Management Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Devices
8.3.3.2.2. By Technique
8.3.3.2.3. By End-Use
8.3.4. Australia Traumatic Brain Injuries Assessment And Management Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Devices
8.3.4.2.2. By Technique
8.3.4.2.3. By End-Use
8.3.5. South Korea Traumatic Brain Injuries Assessment And Management Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Devices
8.3.5.2.2. By Technique
8.3.5.2.3. By End-Use
9. SOUTH AMERICA TRAUMATIC BRAIN INJURIES ASSESSMENT AND MANAGEMENT DEVICES MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Devices (Imaging Devices (Magnetic Resonance Imaging (MRI) Devices, X-Ray, Computed Tomography, Others), Monitoring Devices)
9.2.2. By Technique (Intracranial pressure monitoring, Partial pressure of oxygen in brain tissue (pBrO2))
9.2.3. By End-Use (Hospitals, Diagnostic centers, Others)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Traumatic Brain Injuries Assessment And Management Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Devices
9.3.1.2.2. By Technique
9.3.1.2.3. By End-Use
9.3.2. Argentina Traumatic Brain Injuries Assessment And Management Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Devices
9.3.2.2.2. By Technique
9.3.2.2.3. By End-Use
9.3.3. Colombia Traumatic Brain Injuries Assessment And Management Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Devices
9.3.3.2.2. By Technique
9.3.3.2.3. By End-Use
10. MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURIES ASSESSMENT AND MANAGEMENT DEVICES MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Devices (Imaging Devices (Magnetic Resonance Imaging (MRI) Devices, X-Ray, Computed Tomography, Others), Monitoring Devices)
10.2.2. By Technique (Intracranial pressure monitoring, Partial pressure of oxygen in brain tissue (pBrO2))
10.2.3. By End-Use (Hospitals, Diagnostic centers, Others)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Traumatic Brain Injuries Assessment And Management Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Devices
10.3.1.2.2. By Technique
10.3.1.2.3. By End-Use
10.3.2. Saudi Arabia Traumatic Brain Injuries Assessment And Management Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Devices
10.3.2.2.2. By Technique
10.3.2.2.3. By End-Use
10.3.3. UAE Traumatic Brain Injuries Assessment And Management Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Devices
10.3.3.2.2. By Technique
10.3.3.2.3. By End-Use
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. PORTER’S FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. COMPETITIVE LANDSCAPE
14.1. Integra LifeSciences Corp
14.1.1. Business Overview
14.1.2. Product Offerings
14.1.3. Recent Developments
14.1.4. Financials (As Reported)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. BioDirection Inc
14.3. Nihon Kohden Tokyo Corp
14.4. Compumedics Ltd
14.5. InfraScan Inc
14.6. Oculogica Inc
14.7. RAUMEDIC AG
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL TRAUMATIC BRAIN INJURIES ASSESSMENT AND MANAGEMENT DEVICES MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Devices (Imaging Devices (Magnetic Resonance Imaging (MRI) Devices, X-Ray, Computed Tomography, Others), Monitoring Devices)
5.2.2. By Technique (Intracranial pressure monitoring, Partial pressure of oxygen in brain tissue (pBrO2))
5.2.3. By End-Use (Hospitals, Diagnostic centers, Others)
5.2.4. By Region
5.2.5. By Company (2022)
5.3. Product Market Map
5.3.1. By Devices
5.3.2. By Technique
5.3.3. By End-Use
5.3.4. By Region
6. NORTH AMERICA TRAUMATIC BRAIN INJURIES ASSESSMENT AND MANAGEMENT DEVICES MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Devices (Imaging Devices (Magnetic Resonance Imaging (MRI) Devices, X-Ray, Computed Tomography, Others), Monitoring Devices)
6.2.2. By Technique (Intracranial pressure monitoring, Partial pressure of oxygen in brain tissue (pBrO2))
6.2.3. By End-Use (Hospitals, Diagnostic centers, Others)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Traumatic Brain Injuries Assessment And Management Devices Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Devices
6.3.1.2.2. By Technique
6.3.1.2.3. By End-Use
6.3.2. Canada Traumatic Brain Injuries Assessment And Management Devices Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Devices
6.3.2.2.2. By Technique
6.3.2.2.3. By End-Use
6.3.3. Mexico Traumatic Brain Injuries Assessment And Management Devices Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Devices
6.3.3.2.2. By Technique
6.3.3.2.3. By End-Use
7. EUROPE TRAUMATIC BRAIN INJURIES ASSESSMENT AND MANAGEMENT DEVICES MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Devices (Imaging Devices (Magnetic Resonance Imaging (MRI) Devices, X-Ray, Computed Tomography, Others), Monitoring Devices)
7.2.2. By Technique (Intracranial pressure monitoring, Partial pressure of oxygen in brain tissue (pBrO2))
7.2.3. By End-Use (Hospitals, Diagnostic centers, Others)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Traumatic Brain Injuries Assessment And Management Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Devices
7.3.1.2.2. By Technique
7.3.1.2.3. By End-Use
7.3.2. United Kingdom Traumatic Brain Injuries Assessment And Management Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Devices
7.3.2.2.2. By Technique
7.3.2.2.3. By End-Use
7.3.3. France Traumatic Brain Injuries Assessment And Management Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Devices
7.3.3.2.2. By Technique
7.3.3.2.3. By End-Use
7.3.4. Italy Traumatic Brain Injuries Assessment And Management Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Devices
7.3.4.2.2. By Technique
7.3.4.2.3. By End-Use
7.3.5. Spain Traumatic Brain Injuries Assessment And Management Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Devices
7.3.5.2.2. By Technique
7.3.5.2.3. By End-Use
8. ASIA-PACIFIC TRAUMATIC BRAIN INJURIES ASSESSMENT AND MANAGEMENT DEVICES MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Devices (Imaging Devices (Magnetic Resonance Imaging (MRI) Devices, X-Ray, Computed Tomography, Others), Monitoring Devices)
8.2.2. By Technique (Intracranial pressure monitoring, Partial pressure of oxygen in brain tissue (pBrO2))
8.2.3. By End-Use (Hospitals, Diagnostic centers, Others)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Traumatic Brain Injuries Assessment And Management Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Devices
8.3.1.2.2. By Technique
8.3.1.2.3. By End-Use
8.3.2. Japan Traumatic Brain Injuries Assessment And Management Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Devices
8.3.2.2.2. By Technique
8.3.2.2.3. By End-Use
8.3.3. India Traumatic Brain Injuries Assessment And Management Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Devices
8.3.3.2.2. By Technique
8.3.3.2.3. By End-Use
8.3.4. Australia Traumatic Brain Injuries Assessment And Management Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Devices
8.3.4.2.2. By Technique
8.3.4.2.3. By End-Use
8.3.5. South Korea Traumatic Brain Injuries Assessment And Management Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Devices
8.3.5.2.2. By Technique
8.3.5.2.3. By End-Use
9. SOUTH AMERICA TRAUMATIC BRAIN INJURIES ASSESSMENT AND MANAGEMENT DEVICES MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Devices (Imaging Devices (Magnetic Resonance Imaging (MRI) Devices, X-Ray, Computed Tomography, Others), Monitoring Devices)
9.2.2. By Technique (Intracranial pressure monitoring, Partial pressure of oxygen in brain tissue (pBrO2))
9.2.3. By End-Use (Hospitals, Diagnostic centers, Others)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Traumatic Brain Injuries Assessment And Management Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Devices
9.3.1.2.2. By Technique
9.3.1.2.3. By End-Use
9.3.2. Argentina Traumatic Brain Injuries Assessment And Management Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Devices
9.3.2.2.2. By Technique
9.3.2.2.3. By End-Use
9.3.3. Colombia Traumatic Brain Injuries Assessment And Management Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Devices
9.3.3.2.2. By Technique
9.3.3.2.3. By End-Use
10. MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURIES ASSESSMENT AND MANAGEMENT DEVICES MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Devices (Imaging Devices (Magnetic Resonance Imaging (MRI) Devices, X-Ray, Computed Tomography, Others), Monitoring Devices)
10.2.2. By Technique (Intracranial pressure monitoring, Partial pressure of oxygen in brain tissue (pBrO2))
10.2.3. By End-Use (Hospitals, Diagnostic centers, Others)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Traumatic Brain Injuries Assessment And Management Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Devices
10.3.1.2.2. By Technique
10.3.1.2.3. By End-Use
10.3.2. Saudi Arabia Traumatic Brain Injuries Assessment And Management Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Devices
10.3.2.2.2. By Technique
10.3.2.2.3. By End-Use
10.3.3. UAE Traumatic Brain Injuries Assessment And Management Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Devices
10.3.3.2.2. By Technique
10.3.3.2.3. By End-Use
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. PORTER’S FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. COMPETITIVE LANDSCAPE
14.1. Integra LifeSciences Corp
14.1.1. Business Overview
14.1.2. Product Offerings
14.1.3. Recent Developments
14.1.4. Financials (As Reported)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. BioDirection Inc
14.3. Nihon Kohden Tokyo Corp
14.4. Compumedics Ltd
14.5. InfraScan Inc
14.6. Oculogica Inc
14.7. RAUMEDIC AG
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
